BioCentury | Apr 3, 2008
Distillery Therapeutics

This Week in Therapeutics

...virus (HSV-1) Paired immunoglobulin-like type 2 receptor-a (PILRa) An in vitro study suggests that blocking PILRa...
...HSV-1 infection. PILRa was identified as a host receptor for viral glycoprotein B. Antibodies against PILRa...
...Further studies are necessary to develop small molecules that block interactions between glycoprotein B and PILRa...
Items per page:
1 - 1 of 1